A proof-of-concept formative trial evaluating the interest of multiple connected devices for the early detection of hand-foot skin reactions in patients treated with regorafenib therapy (FACET).

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The FIND-CRC study, officially titled ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: The PROCEED-CRC study, ...

(RTTNews) - Mainz Biomed NV (MYNZ), a molecular genetics diagnostic company, on Tuesday announced the launch of the eAArly DETECT 2 feasibility study to evaluate its next-generation colorectal cancer ...

Natera Inc. ((NTRA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

In a recent study published in the European Journal of Nutrition, researchers examine the potential link between garlic consumption and the risk of developing colorectal cancer (CRC). Study: Garlic ...